Theratechnologies Stock Quote THTX - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.67

Bid

1.56

Ask

1.69

Volume

147

0.00 Day's Range 0.00

0.88 52 Week Range 3.29

Market Cap

71.729M

Previous Close

1.56

Open

Last Trade

1.66

Last Trade Time

07:16:19

Financial Volume

VWAP

Average Volume (3m)

34,350

Shares Outstanding

45,980,019

Dividend Yield

PE Ratio

-2.99

Earnings Per Share (EPS)

-0.52

Revenue

81.76M

Net Profit

-23.96M

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization... Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.theratech.com

Headquarters

Quebec City, Quebec, Can

Founded

1970

Theratechnologies Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker THTX. The last closing price for Theratechnologies was $1.56. Over the last year, Theratechnologies shares have traded in a share price range of $ 0.88 to $ 3.29.

Theratechnologies currently has 45,980,019 shares outstanding. The market capitalization of Theratechnologies is $71.73 million. Theratechnologies has a price to earnings ratio (PE ratio) of -2.99.

Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Poster highlights durable disease stabilization lasting beyond treatment completionResults suggest a unique, multimodal mechanism of action that differs from other cancer therapeuticsFavorable...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.15	9.86842105263	1.52	1.62	1.43	56402	1.55847447	CS
4	0.37	28.4615384615	1.3	1.74	1.27	66139	1.48052252	CS
12	0.3	21.897810219	1.37	1.74	1.08	34350	1.4041041	CS
26	-0.38	-18.5365853659	2.05	2.05	1.08	42905	1.48906293	CS
52	-0.9308	-35.7889880037	2.6008	3.29	0.88	130962	1.66826833	CS
156	-12.21	-87.9682997118	13.88	17.8396	0.88	127515	6.14613775	CS
260	-13.49	-88.9841688654	15.16	17.8396	0.88	157847	8.52847962	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SERVServe Robotics Inc	$ 11.67 (54.57%)	16.59M
RRRichtech Robotics Inc	$ 1.92 (30.61%)	8.15M
NCPLNetcapital Inc	$ 0.1341 (28.94%)	20.43M
CISOCISO Global Inc	$ 0.743 (24.87%)	1.52M
MLGOMicroAlgo Inc	$ 3.21 (20.22%)	2.52M
HUBCWHub Cyber Security Ltd	$ 0.0121 (-47.39%)	1.65k
XCURExicure Inc	$ 0.39 (-27.12%)	162.12k
VVOSVivos Therapeutics Inc	$ 2.05 (-16.33%)	1
SNTGSentage Holdings Inc	$ 2.14 (-13.71%)	19.59k
RYAAYRyanair Holdings PLC	$ 98.79 (-13.58%)	35.5k
NCPLNetcapital Inc	$ 0.1341 (28.94%)	20.43M
SERVServe Robotics Inc	$ 11.67 (54.57%)	16.59M
RRRichtech Robotics Inc	$ 1.92 (30.61%)	8.15M
MAXNMaxeon Solar Technologies Ltd	$ 0.225 (4.36%)	2.85M
SQQQProShares UltraPro Short QQQ	$ 8.25 (-2.48%)	2.76M